Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs: Sequence of two new Cw alleles (Cw*02023 and CW*0707) and recognition by cytotoxic T lymphocytes

Tissue Antigens

Volumn 49, Issue 6, 1997, Pages 612-623

  Grundschober, C ^a   Rufer, N ^a   Sanchez Mazas, A ^b   Madrigal, A ^c   Jeannet, M ^a   Roosnek, E ^a   Tiercy, J M ^a,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d Centre Médical Universitaire   (Switzerland)

Author keywords

Bone marrow transplantation; CTL; Cw*1601 transfectant; HLA haplotype frequency; HLA C; Incompatibility; Oligotyping; Unrelated donor

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; EXON; HLA MATCHING; HLA TYPING; HUMAN; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030996062     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02809.x     Document Type: Article

References (46)

1. 2 microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 1988: 18: 801-810.
2. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low level of HLA-C expression at cell surface correlates with increased turnover of heavy chain mRNA. J Exp Med 1995: 181: 2085-2095.
3. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 1993: 178: 1321-1326.
4. Biassoni R, Falco M, Cambiaggi A et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995: 182: 605-609.
5. Dill O, Kievits F, Koch S, Ivanyi P, Hämmerling GJ. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci U S A 1988: 85: 5664-5668.
6. Bunce M and Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994: 43: 7 17.
7. Petersdorf EW, Stanley JF, Martin PJ, Hansen JA. Molecular diversity of the HLA-C locus in unrelated marrow transplantation. Tissue Antigens 1994: 44: 93-99.
8. Levine JE, Yang SY. SSOP typing of the tenth international histocompatibility workshop reference cell lines for HLA-C alleles. Tissue Antigens 1994: 44: 174-183.
9. Kennedy LJ, Poulton KV, Dyer PA, Ollier WER, Thomson W. Definition of HLA-C alleles using sequence-specific oligonucleotide probes (PCR-SSOP). Tissue Antigens 1995: 46: 187-195.
10. Tiercy J-M, Morel C, Freidel AC et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 1991: 88: 7121.
11. Tiercy J-M, Roosnek E, Speiser D et al. Replacement of HLA class II serology by the HLA-DR microtitre plate oligotyping assay: a one-year experience in unrelated bone marrow donor selection. Br J Haematol 1993: 85: 417-418.
12. Roosnek E, Hogendijk S, Zawadinsky S et al. The frequency of pretrunsplant donor cytotoxic T cell precursor with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation 1993: 56: 691-696.
13. Rufer N, Tiercy J-M, Breur-Vriesendorp B et al. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995: 16: 641-646.
14. Tiercy J-M, Djavad N, Rufer N, Speiser D, Jeannet M, Roosnek E. Oligotyping of HLA-A2, A3, and B44 subtypes: detection of subtype-incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Immunol 1994: 41: 207-215.
15. Gauchat-Feiss D, Rufer N, Speiser D, Jeannet M, Roosnek E, Tiercy J-M. Heterogeneity of HLA-B35: oligotyping and direct sequencing for B35 subtypes reveals a high mismatching rate in B35 serologically compatible kidney and bone marrow donor recipient pairs. Transplantation 1995: 60: 869-873
16. Rufer N, Breur-Vriesendorp B, Tiercy J-M et al. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Hum Immunol 1993: 38: 235-239.
17. Rufer N, Breur-Vriesendorp B, Tiercy J-M et al. HLA-B35-subtype mismatches in ABDR serologically matched unrelated donor-recipient pairs. Hum Immunol 1994: 41: 96-101.
18. Grundschober C, Rufer N, Adami M, Breur-Vriesendorp B, Jeannet M, Roosnek E, Tiercy J-M. Sequence of a new HLA-B7 variant, B*0707, that differs from the common B*0702 allele by one single residue in the peptide binding groove. Tissue Antigens 1997: 49: 508-511.
19. Cros P, Allibert P, Mandrand B, Tiercy J-M, Mach B. Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet 1992: 340: 870-873.
20. Tiercy J-M, Grundschober C, Jeannet M, Mach B. A comprehensive HLA-DRB, -DQB, and -DPB oligotyping procedure by hybridization with sequence-specific oligonucleotide probes. In: Bidwell J, Hui K. ed. Handbook for HLA tissue typing laboratories, Boca Raton, FL: CRC Press, 1993: 117-147.
21. Zetterquist H, Olerup O. Identification of the HLA-DRB1*04, -DRB1*07, and DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992: 34: 64-74.
22. Cereb N, Maye P, Lee S, Kong Y, Yang SY. Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens 1995: 45: 1-11.
23. Marsh S. Nomenclature for factors of the HLA system, update February 1996. Tissue Antigens 1996: 47: 360.
24. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med 1992: 176: 937-950.
25. Lin AY, Devaux B, Green A, Sagerström C, Elliott J, Davis MM. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 1990: 249: 677-679.
26. Shimizu Y, DeMars R. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J Immunol 1989: 142: 3320-3328.
27. Grundschober C, Sanchez-Mazas A, Fxcoffier L, Langaney A, Jeannet M, Tiercy J-M. HLA-DPB1 DNA polymorphism in the Swiss population: linkage disequilibrium with other HLA loci and population genetic affinities. Eur J Immunogenet 1994: 21: 143-157.
28. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies of HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992, vol 1: 1065-1220.
29. Vilches C, Herrero MJ, de Pablo R, Moreno ME, Bunce M, Kreisler M. Molecular characterization of a novel, serologically not detectable, HLA-C allele:Cw*1602. Hum Immunol 1994: 41: 167-170.
30. Steinle A, Reinhardt C, Nössner E, Uchansk-Ziegler B, Ziegler A, Schendel DJ. Microheterogeneity in HLA-B35 alleles influences peptide-dependant allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody. Hum Immunol 1993: 38: 161-269.
31. Breur-Vriesendorp B, Ivanyi P. Self-restricted primary human histocompatibility leukocytes antigen (HLA)-specific cytotoxic T lymphocytes. Int Immunol 1993: 5: 103-107.
32. Srivastava R, Duceman BW, Biro PA, Sood AK, Weissman SM. Molecular organisation of the class I genes of human major histocompatibility complex. Immunol Rev 1985: 84: 93-121.
33. Wang H, Tokunaga K, Ishikawa Y et al. Identification and DNA typing of two Cw7 alleles (Cw*0702 and Cw*0704) in Japanese, with the corrected sequence of Cw*0702. Hum Immunol 1996: 45: 52-59.
34. Arnett KI, Parham P. HLA class I nucleotides sequences. Tissue Antigens 1995: 45: 217-257.
35. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
36. Cereb N, Kong Y, Lee S, Maye P, Yang SY. Nucleotide sequences of MHC class I introns 1, 2, and 3 in humans and intron 2 in nonhuman primates. Tissue Antigens 1996: 47: 498-511.
37. Choo SY, Starling GC, Anasetti C, Hansen JA. Selection of an unrelated donor for marrow transplantation facilitated by the molecular characterization of a novel HLA-A allele. Hum Immunol 1993: 36: 20-26.
38. Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995: 23: 1667-1675.
39. Barnardo MCNM, Davey NJ, Bunce M et al. A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 1996: 61: 1420-1423.
40. Santamaria P, Reinsmoen NL, Lindstrom AL et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identicul unrelated bone marrow transplant pairs. Blood 1994: 83: 280-287.
41. Hansen JA, Anasetti C, Petersdorf E, Clift RA, Martin PJ. Marrow transplants from unrelated donors. Transplant Proc 1994: 26: 1710-1712.
42. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989: 320: 197-204.
43. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993: 81: 543-550.
44. Davies SM, Shu XO, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995: 86: 1636-1642.
45. Spencer A, Brookes PA, Kaminski E et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Transplantation 1995: 59: 1302-1305.
46. Speiser DE, Tiercy J-M, Rufer N et al. High resolution matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996: 87: 4455-4462.